Urban Particulate Matter Impairment of Airway Surface Liquid-Mediated Coronavirus Inactivation

J Infect Dis. 2022 Jan 18;225(2):214-218. doi: 10.1093/infdis/jiab545.

Abstract

Air pollution particulate matter (PM) is associated with SARS-CoV-2 infection and severity, although mechanistic studies are lacking. We tested whether airway surface liquid (ASL) from primary human airway epithelial cells is antiviral against SARS-CoV-2 and human alphacoronavirus 229E (CoV-229E) (responsible for common colds), and whether PM (urban, indoor air pollution [IAP], volcanic ash) affected ASL antiviral activity. ASL inactivated SARS-CoV-2 and CoV-229E. Independently, urban PM also decreased SARS-CoV-2 and CoV-229E infection, and IAP PM decreased CoV-229E infection. However, in combination, urban PM impaired ASL's antiviral activity against both viruses, and the same effect occurred for IAP PM and ash against SARS-CoV-2, suggesting that PM may enhance SARS-CoV-2 infection.

Keywords: COVID-19; airway; common cold; innate immunity; viral infection.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents / pharmacology
  • COVID-19* / prevention & control
  • COVID-19* / transmission
  • Coronavirus 229E, Human*
  • Humans
  • Immunity, Innate*
  • Particulate Matter / adverse effects*
  • Polymerase Chain Reaction
  • SARS-CoV-2
  • Urban Health
  • Urban Population*

Substances

  • Antiviral Agents
  • Particulate Matter